Cancer Therapies Market in Europe 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	146 Pages	TechNavio	December, 2024	INF19463023

Best Price Guarantee
Price	from $2,500
Length	146 Pages
Publisher	TechNavio
Published Date	December, 2024
SKU	INF19463023

Cancer Therapies Market In Europe 2024-2028

The cancer therapies market in europe is forecasted to grow by USD 28.6 bn during 2023-2028, accelerating at a CAGR of 6.7% during the forecast period. The report on the cancer therapies market in europe provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased prevalence of cancer, introduction of combination therapies, and increasing awareness about effective therapies in patient population.

Technavio's cancer therapies market in europe is segmented as below:

By Type

Chemotherapy
Targeted therapy
Immunotherapy
Others

By Geographical Landscape

Europe

This study identifies the rise in research and development investment as one of the prime reasons driving the cancer therapies market in europe growth during the next few years. Also, advent of gene therapy and personalized therapeutics will lead to sizable demand in the market.

The report on the cancer therapies market in europe covers the following areas:

Cancer Therapies Market in Europe sizing
Cancer Therapies Market in Europe forecast
Cancer Therapies Market in Europe industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cancer therapies market in europe vendors that include AbbVie Inc., Amgen Inc., Apotex Inc., AstraZeneca Plc, Bayer AG, Bristol Myers Squibb Co., Cipla Inc., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius Kabi AG, GlaxoSmithKline Plc, Lupin Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., and Viatris Inc.. Also, the cancer therapies market in europe analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Country Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value Chain Analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2023; 4.4 Market outlook: Forecast for 2023-2028; Chart on Europe - Market size and forecast 2023-2028 ($ billion); Data Table on Regional - Market size and forecast 2023-2028 ($ billion); Chart on Europe: Year-over-year growth 2023-2028 (%); Data Table on Regional - Market size and forecast 2023-2028 ($ billion)
5 Historic Market Size: 5.1 Cancer Therapies Market in Europe 2018 - 2022; Historic Market Size - Data Table on Cancer Therapies Market in Europe 2018 - 2022 ($ billion); 5.2 Type segment analysis 2018 - 2022; Historic Market Size - Type Segment 2018 - 2022 ($ billion); 5.3 Geography segment analysis 2018 - 2022; Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
6 Qualitative Analysis: 6.1 The impact of AI in Cancer Therapies Market in Europe
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2023 and 2028; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2023 and 2028; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2023 and 2028; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2023 and 2028; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2023 and 2028; 7.7 Market condition; Chart on Market condition - Five forces 2023 and 2028
8 Market Segmentation by Type: 8.1 Market segments; Chart on Type - Market share 2023-2028 (%); Data Table on Type - Market share 2023-2028 (%); 8.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 8.3 Chemotherapy - Market size and forecast 2023-2028; Chart on Chemotherapy - Market size and forecast 2023-2028 ($ billion); Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ billion); Chart on Chemotherapy - Year-over-year growth 2023-2028 (%); Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%); 8.4 Targeted therapy - Market size and forecast 2023-2028; Chart on Targeted therapy - Market size and forecast 2023-2028 ($ billion); Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ billion); Chart on Targeted therapy - Year-over-year growth 2023-2028 (%); Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%); 8.5 Immunotherapy - Market size and forecast 2023-2028; Chart on Immunotherapy - Market size and forecast 2023-2028 ($ billion); Data Table on Immunotherapy - Market size and forecast 2023-2028 ($ billion); Chart on Immunotherapy - Year-over-year growth 2023-2028 (%); Data Table on Immunotherapy - Year-over-year growth 2023-2028 (%); 8.6 Others - Market size and forecast 2023-2028; Chart on Others - Market size and forecast 2023-2028 ($ billion); Data Table on Others - Market size and forecast 2023-2028 ($ billion); Chart on Others - Year-over-year growth 2023-2028 (%); Data Table on Others - Year-over-year growth 2023-2028 (%); 8.7 Market opportunity by Type; Market opportunity by Type ($ billion); Data Table on Market opportunity by Type ($ billion)
9 Customer Landscape: 9.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
10 Geographic Landscape: 10.1 Geographic segmentation; Chart on Market share By Geographical Landscape - 2023-2028 (%); Data Table on Market share By Geographical Landscape - 2023-2028 (%); 10.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 10.3 Germany - Market size and forecast 2023-2028; Chart on Germany - Market size and forecast 2023-2028 ($ billion); Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Chart on Germany - Year-over-year growth 2023-2028 (%); Data Table on Germany - Year-over-year growth 2023-2028 (%); 10.4 UK - Market size and forecast 2023-2028; Chart on UK - Market size and forecast 2023-2028 ($ billion); Data Table on UK - Market size and forecast 2023-2028 ($ billion); Chart on UK - Year-over-year growth 2023-2028 (%); Data Table on UK - Year-over-year growth 2023-2028 (%); 10.5 France - Market size and forecast 2023-2028; Chart on France - Market size and forecast 2023-2028 ($ billion); Data Table on France - Market size and forecast 2023-2028 ($ billion); Chart on France - Year-over-year growth 2023-2028 (%); Data Table on France - Year-over-year growth 2023-2028 (%); 10.6 Italy - Market size and forecast 2023-2028; Chart on Italy - Market size and forecast 2023-2028 ($ billion); Data Table on Italy - Market size and forecast 2023-2028 ($ billion); Chart on Italy - Year-over-year growth 2023-2028 (%); Data Table on Italy - Year-over-year growth 2023-2028 (%); 10.7 Rest of Europe - Market size and forecast 2023-2028; Chart on Rest of Europe - Market size and forecast 2023-2028 ($ billion); Data Table on Rest of Europe - Market size and forecast 2023-2028 ($ billion); Chart on Rest of Europe - Year-over-year growth 2023-2028 (%); Data Table on Rest of Europe - Year-over-year growth 2023-2028 (%); 10.8 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ billion); Data Table on Market opportunity By Geographical Landscape ($ billion)
11 Drivers, Challenges, and Opportunity/Restraints: 11.1 Market drivers; 11.2 Market challenges; 11.3 Impact of drivers and challenges; Impact of drivers and challenges in 2023 and 2028; 11.4 Market opportunities/restraints
12 Competitive Landscape: 12.1 Overview; 12.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 12.3 Landscape disruption; Overview on factors of disruption; 12.4 Industry risks; Impact of key risks on business
13 Competitive Analysis: 13.1 Companies profiled; Companies covered; 13.2 Company ranking index; Company ranking index; 13.3 Market positioning of companies; Matrix on companies position and classification; 13.4 Amgen Inc.; Amgen Inc. - Overview; Amgen Inc. - Product / Service; Amgen Inc. - Key news; Amgen Inc. - Key offerings; SWOT; 13.5 AstraZeneca Plc; AstraZeneca Plc - Overview; AstraZeneca Plc - Product / Service; AstraZeneca Plc - Key news; AstraZeneca Plc - Key offerings; SWOT; 13.6 Bayer AG; Bayer AG - Overview; Bayer AG - Business segments; Bayer AG - Key news; Bayer AG - Key offerings; Bayer AG - Segment focus; SWOT; 13.7 Bristol Myers Squibb Co.; Bristol Myers Squibb Co. - Overview; Bristol Myers Squibb Co. - Product / Service; Bristol Myers Squibb Co. - Key news; Bristol Myers Squibb Co. - Key offerings; SWOT; 13.8 Eli Lilly and Co.; Eli Lilly and Co. - Overview; Eli Lilly and Co. - Product / Service; Eli Lilly and Co. - Key offerings; SWOT; 13.9 F. Hoffmann La Roche Ltd.; F. Hoffmann La Roche Ltd. - Overview; F. Hoffmann La Roche Ltd. - Business segments; F. Hoffmann La Roche Ltd. - Key news; F. Hoffmann La Roche Ltd. - Key offerings; F. Hoffmann La Roche Ltd. - Segment focus; SWOT; 13.10 GlaxoSmithKline Plc; GlaxoSmithKline Plc - Overview; GlaxoSmithKline Plc - Business segments; GlaxoSmithKline Plc - Key news; GlaxoSmithKline Plc - Key offerings; GlaxoSmithKline Plc - Segment focus; SWOT; 13.11 Merck and Co. Inc.; Merck and Co. Inc. - Overview; Merck and Co. Inc. - Business segments; Merck and Co. Inc. - Key news; Merck and Co. Inc. - Key offerings; Merck and Co. Inc. - Segment focus; SWOT; 13.12 Novartis AG; Novartis AG - Overview; Novartis AG - Business segments; Novartis AG - Key news; Novartis AG - Key offerings; Novartis AG - Segment focus; SWOT; 13.13 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; SWOT
14 Appendix: 14.1 Scope of the report; 14.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 14.3 Currency conversion rates for US$; Currency conversion rates for US$; 14.4 Research methodology; Research methodology; 14.5 Data procurement; Information sources; 14.6 Data validation; Data validation; 14.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 14.8 Data synthesis; Data synthesis; 14.9 360 degree market analysis; 360 degree market analysis; 14.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Country Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Type; Exhibits6: Executive Summary - Chart on Incremental Growth; Exhibits7: Executive Summary - Data Table on Incremental Growth; Exhibits8: Executive Summary - Chart on Company Market Positioning; Exhibits9: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits10: Overview on criticality of inputs and factors of differentiation; Exhibits11: Overview on factors of disruption; Exhibits12: Impact of drivers and challenges in 2023 and 2028; Exhibits13: Parent Market; Exhibits14: Data Table on - Parent Market; Exhibits15: Market characteristics analysis; Exhibits16: Value Chain Analysis; Exhibits17: Offerings of companies included in the market definition; Exhibits18: Market segments; Exhibits19: Chart on Europe - Market size and forecast 2023-2028 ($ billion); Exhibits20: Data Table on Regional - Market size and forecast 2023-2028 ($ billion); Exhibits21: Chart on Europe: Year-over-year growth 2023-2028 (%); Exhibits22: Data Table on Regional - Market size and forecast 2023-2028 ($ billion); Exhibits23: Historic Market Size - Data Table on Cancer Therapies Market in Europe 2018 - 2022 ($ billion); Exhibits24: Historic Market Size - Type Segment 2018 - 2022 ($ billion); Exhibits25: Historic Market Size - Geography Segment 2018 - 2022 ($ billion); Exhibits26: Five forces analysis - Comparison between 2023 and 2028; Exhibits27: Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits28: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits29: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits30: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits31: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits32: Chart on Market condition - Five forces 2023 and 2028; Exhibits33: Chart on Type - Market share 2023-2028 (%); Exhibits34: Data Table on Type - Market share 2023-2028 (%); Exhibits35: Chart on Comparison by Type; Exhibits36: Data Table on Comparison by Type; Exhibits37: Chart on Chemotherapy - Market size and forecast 2023-2028 ($ billion); Exhibits38: Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ billion); Exhibits39: Chart on Chemotherapy - Year-over-year growth 2023-2028 (%); Exhibits40: Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%); Exhibits41: Chart on Targeted therapy - Market size and forecast 2023-2028 ($ billion); Exhibits42: Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ billion); Exhibits43: Chart on Targeted therapy - Year-over-year growth 2023-2028 (%); Exhibits44: Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%); Exhibits45: Chart on Immunotherapy - Market size and forecast 2023-2028 ($ billion); Exhibits46: Data Table on Immunotherapy - Market size and forecast 2023-2028 ($ billion); Exhibits47: Chart on Immunotherapy - Year-over-year growth 2023-2028 (%); Exhibits48: Data Table on Immunotherapy - Year-over-year growth 2023-2028 (%); Exhibits49: Chart on Others - Market size and forecast 2023-2028 ($ billion); Exhibits50: Data Table on Others - Market size and forecast 2023-2028 ($ billion); Exhibits51: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits52: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits53: Market opportunity by Type ($ billion); Exhibits54: Data Table on Market opportunity by Type ($ billion); Exhibits55: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits56: Chart on Market share By Geographical Landscape - 2023-2028 (%); Exhibits57: Data Table on Market share By Geographical Landscape - 2023-2028 (%); Exhibits58: Chart on Geographic comparison; Exhibits59: Data Table on Geographic comparison; Exhibits60: Chart on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits61: Data Table on Germany - Market size and forecast 2023-2028 ($ billion); Exhibits62: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits63: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits64: Chart on UK - Market size and forecast 2023-2028 ($ billion); Exhibits65: Data Table on UK - Market size and forecast 2023-2028 ($ billion); Exhibits66: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits67: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits68: Chart on France - Market size and forecast 2023-2028 ($ billion); Exhibits69: Data Table on France - Market size and forecast 2023-2028 ($ billion); Exhibits70: Chart on France - Year-over-year growth 2023-2028 (%); Exhibits71: Data Table on France - Year-over-year growth 2023-2028 (%); Exhibits72: Chart on Italy - Market size and forecast 2023-2028 ($ billion); Exhibits73: Data Table on Italy - Market size and forecast 2023-2028 ($ billion); Exhibits74: Chart on Italy - Year-over-year growth 2023-2028 (%); Exhibits75: Data Table on Italy - Year-over-year growth 2023-2028 (%); Exhibits76: Chart on Rest of Europe - Market size and forecast 2023-2028 ($ billion); Exhibits77: Data Table on Rest of Europe - Market size and forecast 2023-2028 ($ billion); Exhibits78: Chart on Rest of Europe - Year-over-year growth 2023-2028 (%); Exhibits79: Data Table on Rest of Europe - Year-over-year growth 2023-2028 (%); Exhibits80: Market opportunity By Geographical Landscape ($ billion); Exhibits81: Data Table on Market opportunity By Geographical Landscape ($ billion); Exhibits82: Impact of drivers and challenges in 2023 and 2028; Exhibits83: Overview on criticality of inputs and factors of differentiation; Exhibits84: Overview on factors of disruption; Exhibits85: Impact of key risks on business; Exhibits86: Companies covered; Exhibits87: Company ranking index; Exhibits88: Matrix on companies position and classification; Exhibits89: Amgen Inc. - Overview; Exhibits90: Amgen Inc. - Product / Service; Exhibits91: Amgen Inc. - Key news; Exhibits92: Amgen Inc. - Key offerings; Exhibits93: SWOT; Exhibits94: AstraZeneca Plc - Overview; Exhibits95: AstraZeneca Plc - Product / Service; Exhibits96: AstraZeneca Plc - Key news; Exhibits97: AstraZeneca Plc - Key offerings; Exhibits98: SWOT; Exhibits99: Bayer AG - Overview; Exhibits100: Bayer AG - Business segments; Exhibits101: Bayer AG - Key news; Exhibits102: Bayer AG - Key offerings; Exhibits103: Bayer AG - Segment focus; Exhibits104: SWOT; Exhibits105: Bristol Myers Squibb Co. - Overview; Exhibits106: Bristol Myers Squibb Co. - Product / Service; Exhibits107: Bristol Myers Squibb Co. - Key news; Exhibits108: Bristol Myers Squibb Co. - Key offerings; Exhibits109: SWOT; Exhibits110: Eli Lilly and Co. - Overview; Exhibits111: Eli Lilly and Co. - Product / Service; Exhibits112: Eli Lilly and Co. - Key offerings; Exhibits113: SWOT; Exhibits114: F. Hoffmann La Roche Ltd. - Overview; Exhibits115: F. Hoffmann La Roche Ltd. - Business segments; Exhibits116: F. Hoffmann La Roche Ltd. - Key news; Exhibits117: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits118: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits119: SWOT; Exhibits120: GlaxoSmithKline Plc - Overview; Exhibits121: GlaxoSmithKline Plc - Business segments; Exhibits122: GlaxoSmithKline Plc - Key news; Exhibits123: GlaxoSmithKline Plc - Key offerings; Exhibits124: GlaxoSmithKline Plc - Segment focus; Exhibits125: SWOT; Exhibits126: Merck and Co. Inc. - Overview; Exhibits127: Merck and Co. Inc. - Business segments; Exhibits128: Merck and Co. Inc. - Key news; Exhibits129: Merck and Co. Inc. - Key offerings; Exhibits130: Merck and Co. Inc. - Segment focus; Exhibits131: SWOT; Exhibits132: Novartis AG - Overview; Exhibits133: Novartis AG - Business segments; Exhibits134: Novartis AG - Key news; Exhibits135: Novartis AG - Key offerings; Exhibits136: Novartis AG - Segment focus; Exhibits137: SWOT; Exhibits138: Pfizer Inc. - Overview; Exhibits139: Pfizer Inc. - Product / Service; Exhibits140: Pfizer Inc. - Key news; Exhibits141: Pfizer Inc. - Key offerings; Exhibits142: SWOT; Exhibits143: Inclusions checklist; Exhibits144: Exclusions checklist; Exhibits145: Currency conversion rates for US$; Exhibits146: Research methodology; Exhibits147: Information sources; Exhibits148: Data validation; Exhibits149: Validation techniques employed for market sizing; Exhibits150: Data synthesis; Exhibits151: 360 degree market analysis; Exhibits152: List of abbreviations